Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals.
Jennifer O LamLeo B HurleyJennifer B LaiVarun SaxenaSuk SeoScott ChamberlandCharles P QuesenberryJamila H ChampsiJoanna ReadyElizabeth Yu ChiaoJulia L MarcusMichael J SilverbergPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
DAA treatment is important for reducing cancer incidence among people with HCV infection.